HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor

被引：44
|
作者：
Lisziewicz, J
Jessen, H
Finzi, D
Siliciano, RF
Lori, F [1 ]
机构：
[1] Georgetown Univ, RIGHT, Washington, DC 20007 USA
[2] Policlin San Matteo, IRCCS, RIGHT, I-27100 Pavia, Italy
[3] Jessen Praxis, Berlin, Germany
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
来源：
LANCET | 1998年 / 352卷 / 9123期
关键词：
D O I：
10.1016/S0140-6736(98)24029-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [1] Long-term suppression of HIV-1 by hydroxyurea and didanosine
    Lori, F
    Jessen, H
    Foli, A
    Lisziewicz, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1437 - 1438
  • [2] Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection
    Rutschmann, OT
    Vernazza, PL
    Bucher, HC
    Opravil, M
    Ledergerber, B
    Telenti, A
    Malinverni, R
    Bernasconi, E
    Fagard, C
    Leduc, D
    Perrin, L
    Hirschel, B
    AIDS, 2000, 14 (14) : 2145 - 2151
  • [3] Hydroxyurea in the treatment of HIV-1
    Gibbs, MA
    Sorensen, SJ
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (01) : 89 - 93
  • [4] HIV-1 protease inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (06) : 261 - 261
  • [5] Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
    Barragan, Patricia
    Podzamczer, Daniel
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2363 - 2375
  • [6] Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine
    De Boer, RJ
    Boucher, CAB
    Perelson, AS
    AIDS, 1998, 12 (13) : 1567 - 1570
  • [7] Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals
    Biron, F
    Lucht, F
    Peyramond, D
    Fresard, A
    Vallet, T
    Nugier, F
    Grange, J
    Malley, S
    HamediSangsari, F
    Vila, J
    ANTIVIRAL RESEARCH, 1996, 29 (01) : 111 - 113
  • [8] Amprenavir - A protease inhibitor for the treatment of patients with HIV-1 infection
    Reddy, P
    Ross, J
    FORMULARY, 1999, 34 (07) : 567 - +
  • [9] A folding inhibitor of the HIV-1 protease
    Broglia, RA
    Provasi, D
    Vasile, F
    Ottolina, G
    Longhi, R
    Tiana, G
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 62 (04) : 928 - 933
  • [10] Efficacy and tolerability of the combination stavudine, didanosine and nevirapine following treatment with HIV-1 protease inhibitors
    Pell, CM
    Donovan, B
    Bodsworth, NJ
    VENEREOLOGY-THE INTERDISCIPLINARY INTERNATIONAL JOURNAL OF SEXUAL HEALTH, 1999, 12 (04): : 145 - 146
12345